PFIZER INC — Director's Dealing 2019

Sep 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-08-30

Reporting Person: Hwang Angela (Group President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-30	Common Stock	I	9896.0000	$35.5500	Acquired	13079.0000	Indirect
2019-05-29	Common Stock	G	240.0000	$0.0000	Disposed	8748.0000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-30	Phantom Stock Units SSP	$	I	13142.0000	Acquired		Common Stock (13142.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19304.0000	Direct

Footnotes

F1: This transaction constitutes an intra-plan transfer into the Pfizer Inc. stock fund under the Pfizer's Qualified Savings Plan.

F2: The reporting person disclaims beneficial ownership of the shares held by spouse.

F3: Each unit represents one phantom share of common stock.

F4: This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.

F5: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.